US PA Philadelphia Falk MJ: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
| Line 13: | Line 13: | ||
|Contact=Falk Marni J | |Contact=Falk Marni J | ||
|MiPNetLab=Polyak Erzsebet | |MiPNetLab=Polyak Erzsebet | ||
|Status=O2k 2008- | |Status=[http://www.oroboros.at/?Power-O2k '''2 Power-O2k'''] 2008- | ||
|info=[[MiPNet19.06 IOC91 |IOC91 Philadelphia]], [http://www.oroboros.at/?IOC47 IOC47] | |info=[[MiPNet19.06 IOC91 |IOC91 Philadelphia]], [http://www.oroboros.at/?IOC47 IOC47] | ||
|keyword=Respiratory OXPHOS disease | |keyword=Respiratory OXPHOS disease | ||
Revision as of 13:24, 22 October 2014
Feedback
- We use the O2k to study permeabilized human cells and permeabilized mouse tissues to assess integrated respiratory capacity in different genetic mutants and in response to specific pharmacologic agents. Marni J Falk
- .. we are very impressed with the instrument .. - Marni J Falk (2009)
